MRNA, LNTH, BMY, CAPR, RARE Stocks In Focus — These FDA Decisions Could Shape August Trading
Decisions are due by August 23 at the latest on therapies ranging from an mRNA flu vaccine to a gene therapy for a rare metabolic disorder, putting biotech investors on high alert. Moderna is seeking approval for mRNA-1010, its experimental mRNA-based seasonal flu vaccine for adults 50 and older. Capricor is seeking full approval for … Read more